Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
NCT ID: NCT06290427
Last Updated: 2025-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-02-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* DaVinci®;
* Hugo®.
The questions it aims to answer are:
Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?
Participants will be invited to join one of these two experimental group:
1. surgery with the DaVinci platform;
2. surgery with the Hugo platform.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate
NCT05766163
Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform
NCT06844513
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NCT06987552
Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy
NCT06846112
CLamp vs Off Clamp Kidney During Partial Nephrectomy
NCT02287987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DaVinci system
Robot-assisted partial nephrectomy is performed using the DaVinci platform
DaVinci RAPN
Robot-assisted Partial Nephrectomy with DaVinci® Surgical System
Hugo RAS system
Robot-assisted partial nephrectomy is performed using the Hugo RAS platform
Hugo RAS RAPN
Robot-assisted Partial Nephrectomy with Hugo™ RAS System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DaVinci RAPN
Robot-assisted Partial Nephrectomy with DaVinci® Surgical System
Hugo RAS RAPN
Robot-assisted Partial Nephrectomy with Hugo™ RAS System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with localized kidney tumor suitable for partial nephrectomy;
* patient able to understand and sign the informed consent;
* patient compliance with the follow-up program.
Exclusion Criteria
* patient not suitable for partial nephrectomy;
* patient unable to understand and sign the informed consent;
* patient unable to follow the monitoring program;
* patient refusal to participate to the study.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera Universitaria Integrata Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessandro Antonelli, MD, Prof
MD, Director of Urology Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandro AA Antonelli, MD
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliera Universitaria Integrata Verona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology Unit, AOUI Verona
Verona, VR, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMPAR-K
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.